Reducing glypican-4 in ES cells improves recovery in a rat model of Parkinson's disease by increasing the production of dopaminergic neurons and decreasing teratoma formation

J Neurosci. 2014 Jun 11;34(24):8318-23. doi: 10.1523/JNEUROSCI.2501-13.2014.

Abstract

The heparan sulfate proteoglycan Glypican 4 (Gpc4) is strongly expressed in mouse embryonic stem (ES) cells where it controls the maintenance of self-renewal by modulating Wnt/β-catenin signaling activities. Here we show that mouse ES cells carrying a hypomorphic Gpc4 allele, in a single-step neuronal differentiation protocol, show increased differentiation into dopaminergic neurons expressing tyrosine hydroxylase (TH) and nuclear receptor related-1 protein (Nurr1) 1. In contrast to wild-type cells, these differentiating Gpc4-mutant cells expressed high levels of DOPA decarboxylase and the dopamine transporter, two markers expressed by fully mature dopaminergic neurons. Intrastriatal transplantation of Gpc4 hypomorphic cells into a 6-OHDA rat model for Parkinson's disease improved motor behavior in the cylinder test and amphetamine-induced rotations at a higher level than transplanted wild-type cells. Importantly, Gpc4 hypomorphic cell grafts, in contrast to wild-type cells, did not generate teratomas in the host brains, leading to strongly enhanced animal survival. Therefore, control of Gpc4 activity level represents a new potential strategy to reduce ES cell tumorigenic features while at the same time increasing neuronal differentiation and integration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calbindins / metabolism
  • Cell Count
  • Cell Differentiation
  • Disease Models, Animal
  • Dopamine Plasma Membrane Transport Proteins / metabolism
  • Dopaminergic Neurons / physiology*
  • Embryonic Stem Cells / transplantation*
  • Glypicans / genetics
  • Glypicans / metabolism*
  • Green Fluorescent Proteins / genetics
  • Green Fluorescent Proteins / metabolism
  • Hepatocyte Nuclear Factor 3-beta / metabolism
  • Humans
  • Mice
  • Motor Activity / drug effects
  • Motor Activity / genetics
  • Parkinson Disease / physiopathology*
  • Parkinson Disease / surgery*
  • Rats
  • Receptors, Dopamine D2 / metabolism
  • Recovery of Function / physiology
  • Teratoma / etiology
  • Teratoma / prevention & control*
  • Tyrosine 3-Monooxygenase / metabolism

Substances

  • Calbindins
  • Dopamine Plasma Membrane Transport Proteins
  • Foxa2 protein, rat
  • Glypicans
  • Receptors, Dopamine D2
  • dopamine D2L receptor
  • Hepatocyte Nuclear Factor 3-beta
  • Green Fluorescent Proteins
  • Tyrosine 3-Monooxygenase